logo
episode-header-image
Dec 2024
28m 6s

The Sunday Read: ‘Ozempic Could Crush th...

The New York Times
About this episode
For decades, Big Food has been marketing products to people who can’t seem to stop eating, and now, suddenly, they can. The active ingredient in new drugs like Ozempic, Wegovy and Zepbound mimics a natural hormone that slows digestion and signals fullness to the brain. Around seven million Americans take these drugs, but estimates from Morgan Stanley sugges ... Show More
Up next
Today
The Unprecedented Personal Profits of Trump’s Presidency
A recent financial disclosure shows that President Trump has made $2.2 billion since he returned to office. Today, Eric Lipton, a New York Times investigative reporter, reveals the Trump family’s next potential windfall and how the president’s position is once again helping it ha ... Show More
29m 56s
Yesterday
The Implosion of Graham Platner
The campaign for Graham Platner, the Democratic nominee for Senate from Maine, imploded this week after he was accused of rape. Lisa Lerer and Shane Goldmacher, national political correspondents for The New York Times, discuss the battle over who should replace him on the ballot ... Show More
35m 28s
Jul 7
The Onion’s Latest Joke: Taking Over Infowars
Last Thursday, the satirical newspaper The Onion started its own version of Infowars, the infamous online hub of misinformation created by Alex Jones. The takeover has been years in the making. After Mr. Jones lost two defamation cases, his assets were put up for auction. The Oni ... Show More
22m 26s
Recommended Episodes
Jul 2023
One Thing: Weight Loss Drugs: Trend or Treatment?
A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ... Show More
17m 14s
Dec 2024
Deep Dive: The Gold Rush to Cure the Obesity Epidemic
<p>GLP-1 weight-loss drugs, such as Novo Nordisk's Ozempic and Eli Lilly's Zepbound, are credited with reversing obesity trends in the U.S. for the first time in decades, according to a new study in the Journal of the American Medical Association. The episode highlights the rapid ... Show More
8m 47s
Oct 2023
Semaglutide: Decoding the hype around the weight loss wonder drug
<p>From Elon Musk to several Hollywood celebrities, the weight loss wonder drug, semaglutide, is taking the world by storm. What was an unintended consequence of a diabetes control med, the emergence of significant weight loss has raised the expectation of the wonder drug becomin ... Show More
32m 7s
Jun 2024
The weight-loss drug revolution
Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of ... Show More
17m 28s
Sep 2023
After Ozempic
Ozempic and other drugs like it are being heralded as game changers for weight loss. Radio Atlantic host Hanna Rosin talks to Atlantic staff writer Olga Khazan about what it means that this medical intervention has arrived at a time when our society seems to be easing away from f ... Show More
24m 15s
Dec 2024
How Ozempic Transformed the Way We Look at Obesity
Ozempic, Wegovy, and Mounjaro, are being called “miracle drugs” with users boasting about their fast results. Dr. Sanjay Gupta takes a deep dive into how they disrupted the entire weight loss industry and changed the conversation about obesity.  Learn more about your ad choices. ... Show More
23m 47s
Jan 2023
The Tiktok trending weight loss drug
<p dir="ltr">Ozempic is a drug used to treat type 2 diabetes and obesity but social media influencers have now turned it into the most popular weight loss drug. Promotion of the drug has led to a shortage of supply with Australia's drugs regulator now investigating the matter. Ho ... Show More
18m 6s